Phase 3 Partial Clinical Trials
4 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–4 of 4 trials
Recruiting
Phase 3
Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy
Familial Partial Lipodystrophy
Chiesi Farmaceutici S.p.A.24 enrolled7 locationsNCT06679270
Recruiting
Phase 3
A Study to Evaluate the Safety, Efficacy, and PK of ONO-2017 in Japanese Patients With POS 2 to 17 Year Olds
Partial Epilepsy
Ono Pharmaceutical Co., Ltd.20 enrolled1 locationNCT07594158
Recruiting
Phase 2Phase 3
A Phase 2b/3 Study of TPX-115 on Partial-thickness Rotator Cuff Tear
Partial Thickness Rotator Cuff Tear
Tego Science, Inc.166 enrolled2 locationsNCT06414005
Completed
Phase 3
Efficacy & Safety of Zonisamide in newly diagnosed partial epilepsy patients.
Newly diagnosed partial epilepsy
Eisai Ltd582 enrolled1 locationACTRN12607000142437